21254 ⎘
Medicinal preparations containing active ingredients not provided for in groups -
Method for suppressing tumors by miR-200 family inhibition
#302Leukocyte infiltration promoting agent and antitumor immunostimulatory agent
#303Pharmaceutical composition for treatment of or remission in elderly or terminal cancer patient
#304METHOD FOR CHANGING CONDITION OF EYELID OF HAIRLESS ANIMAL
#305Immunity enhancing agent for cancer by Allergin-1 antagonist
#306Implant for tissue repair including chitosan
#307Anti-cancer agent comprising HVJ-E and CXCL2
#308Medicine for treatment and/or prevention of ischemic diseases, method for improving angiogenesis-promoting activity of cells, or method for producing medicine
#309Therapeutic agent or treatment method for Philadelphia chromosome-positive (Ph+) acute lymphocytic leukemia (ALL) having IKZF1 mutation
#310Polymeric bile acid nanocompositions targeting the pancreas and colon
#311Circulating astrocytes and MFSD2A as biomarkers
#312Method of treating depression
#313FIBROBLASTS FOR TREATMENT OF DEGENERATIVE DISC DISEASE
#314Methods and products related to glutaminase inhibitors
#315GAMMA SECRETASE MODULATORS FOR THE TREATMENT OF IMMUNE SYSTEM DYSFUNCTION
#316Development of dietary therapy in cancer
#317Methods and compositions for treatment of autoimmune hepatitis
#318INHIBITING CTRP5 ACTION TO IMPROVE INSULIN RESISTANCE ASSOCIATED WITH OBESITY AND TYPE 2 DIABETES
#319Compositions and methods for treating neurodegenerative diseases
#320Immune inducer
#321Bicyclic heterocyclic amide derivative
#322Identification of enzyme activity through determination of its localization
#323Therapeutic agent for mental illness comprising IL-6 inhibitor as active ingredient
#324Brk inhibitory compound
#325CELL MEMBRANE-FORMED NANOSCALE VESICLES AND METHODS OF USING THEREOF
#326Anti-human transferrin receptor antibody permeating blood-brain barrier
#327GPC3-targeting therapeutic agent which is administered to patient for whom the GPC3-targeting therapeutic agent is effective
#328Immunity induction promoting composition, and vaccine pharmaceutical composition
#329FKBP52-TAU INTERACTION AS A NOVEL THERAPEUTICAL TARGET FOR TREATING THE NEUROLOGICAL DISORDERS INVOLVING TAU DYSFUNCTION
#330Cationic lipid
#331METHODS AND DEVICES FOR TREATMENT OF TUMORS WITH NANO-PULSE STIMULATION
#332Composition for inducing proliferation or accumulation of regulatory T cells
#333Method for determining application of therapy to multiple sclerosis (MS) patient
#334Composition for treating IL-6-related diseases
#335Method for selectively manufacturing antibody-drug conjugate
#336Composition including glycosaminoglycan derivative and chemokine receptor activity regulator
#337Cytomegalovirus vectors eliciting T cells restricted by major histocompatibility complex E molecules
#338Impact of electrolytes on tumors and various diseases
#339Methods and formulations for modulating Lyn kinase activity and treating related disorders
#340Method of predicting effect of treatment by PD-1/PD-L1 blockade using abnormality of PD-L1 (CD274) as index
#341Biomarker for mental disease
#342METHODS OF TREATING PROSTATITIS
#343Method for treating cancer by adminstering poly I:C and LAG-3-IgG fusion protein
#344Pharmaceutical composition comprising polypeptide
#345Crystalline forms of a biphenyl compound
#346NUCLEOSIDE PHOSPHORAMIDATES
#347Increasing serum half-life of human IL-11 variants by N-terminal branched PEGylation
#348Pharmaceutical for prophylaxis or treatment of hypertension
#349Gel patch
#350Pyridinone compound and use thereof
#351Cytophilic peptide-fused high-density lipoprotein, and delivery of drug to posterior segment of eye by ocular installation of said fusion
#352ANTIBACTERIAL NASAL COMPOSITIONS AND RELATED METHODS
#353PROSTAGLANDIN TRANSPORTER INHIBITORS FOR INHIBITING OVULATION
#354Screening method for pain suppressor and pharmaceutical composition for prevention or treatment of pain
#355Tricyclic spiro compound
#356Low molecular weight cationic lipids for oligonucleotide delivery
#357Method for modifying T cell population
#358PHARMACEUTICAL COMPOSITION FOR PROMOTION OF FIBRINOLYSIS
#359TREATMENT OF VASCULAR ANOMALIES
#360PHARMACOTHERAPY FOR PREVENTING OR TREATING GLAUCOMA
#361Preparation
#362PROBIOTIC AUGMENTATION OF ANTI-TUMOR ENDOTHELIUM IMMUNE RESPONSES
#363BK Channels as Non-Genomic Estrogen Targets for Overactive Bladder
#364Therapeutic angiogenesis for treating erectile conditions
#365Supported carbon nanotube membranes and their preparation methods
#366BLOCKADE OF TIM-1 PATHWAYS and P-SELECTIN PATHWAYS IN TREATMENT OF NEUROINFLAMMATORY DEGENERATIVE DISEASE
#367Compositions and methods for treating CNS disorders
#368Treatment of cornea using laminin
#369TH1-inducing adjuvant comprising combination of different nucleic acid adjuvants, and use of same
#370Treatment of retina and nerve using laminin
#371Methods and Pharmaceutical Compositions Using Orexins (OXA, OXB) for the Treatment of Prostate Cancers
#372Alcohol metabolism promoter
#373Organic compounds
#374Statin-encapsulated nanoparticle preparation for enhancing stem cell function, stem cell with enhanced function containing statin-encapsulated nanoparticle, and method for producing same
#375METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY DISORDERS
#376Compositions and methods for inhibition of HAO1 (Hydroxyacid Oxidase 1 (Glycolate Oxidase)) gene expression
#377Therapeutic material for skin ulcer
#378NEUROACTIVE COMPOUNDS AND METHODS OF USE THEREOF
#379Dyslipidemia therapeutic agent
#380Antibody-drug conjugate having cyclic benzylidene acetal linker
#381Compositions, methods and kits to detect herpes simplex virus nucleic acids
#382Use of IL-17 antagonists to inhibit the progression of structural damage in psoriatic arthritis patients
#383Oral biofilm inhibitor
#384Process for preparing cholinergic neurons
#385Method of predicting obesity comprising measuring neurotensin
#386Method for evaluating mesenchymal stem cell activity, method for culturing mesenchymal stem cells, method for producing therapeutic agent for liver dysfunction, and therapeutic agent for liver dysfunction
#387Acid-addition salt of Trk-inhibiting compound
#388Cancer diagnosis and therapy
#389Control of cellular redox levels
#390COMPOSITIONS AND METHODS FOR OCULAR DELIVERY OF A THERAPEUTIC AGENT
#391Tyrosine derivatives and compositions comprising them
#392Acellular bioabsorbable tissue regeneration matrices
#393Lytic-peptide-Her2/neu (Human Epidermal growth factor Receptor 2) ligand conjugates and methods of use
#394Method of encapsulating pancreatic islet cells introduced to siRNA against PHLDA3
#395Methods of treatment of primary sclerosing cholangitis
#396Stable antibody-drug conjugate, preparation method therefor, and use thereof
#397Systems and methods for analyzing persistent homeostatic perturbations
#398Compositions and methods for prognosis of ovarian cancer
#399Methods for treating occular irritation involving tearing by administering modulators of TRPM8
#400FKBP52-Tau Interaction as a Novel Therapeutical Target for Treating the Neurological Disorders Involving Tau Dysfunction
#401Method for treating vaginal dryness by administering transient receptor potential cation channel subfamily M member 8 (TRPM8) receptor agonists
#402Liposome composition and method for producing same
#403Delivery system in micellar form having modular spectral response based on enzyme-responsive amphiphilic PEG-dendron hybrid polymers
#404Cadaveric derived wound treatment and method of use
#405CONTRACEPTIVE AND RELATED DEVICE
#406Composition for inducing proliferation or accumulation of regulatory T cells
#407ADHD/OCD Treatment
#408FGF modulation of in vivo antibody production and humoral immunity
#409TREATMENT OF MULTIPLE SCLEROSIS WITH COMBINATION OF LAQUINIMOD AND FAMPRIDINE
#410Pasty bio-adhesive sustained release compositions
#411Base composition for tape agent
#412DIAGNOSTIC METHODS FOR INFECTIOUS DISEASE USING ENDOGENOUS GENE EXPRESSION
#413Methods and compositions for increasing N-acetylglucosaminidase (NAGLU) activity in the CNS using a fusion antibody comprising an anti-human insulin receptor antibody and NAGLU
#414Compositions and methods for the treatment of cancer
#415Methods and materials for treating cancer
#416Treatment for non-genetic biological disease
#417Treatment options for allergies
#418Diagnosis of respiratory tract infectious disease using urine specimens
#419Crystalline forms of a biphenyl compound
#420Diagnosis of respiratory tract infectious disease using blood specimens
#421Composition for inducing proliferation or accumulation of regulatory T cells
#422Methods of using phthalazinone ketone derivatives
#423Composition for inducing proliferation or accumulation of regulatory T cells
#424Method for predicting post-therapy prognosis of relapsing-remitting multiple sclerosis (RRMS) patient, and method for determining applicability of novel therapy
#425Methods and formulations for modulating Lyn kinase activity and treating related disorders
#426Lipoprotein complexes and manufacturing and uses thereof
#427Topical transdermal method for delivering nutrients through the skin for expeditied wound healing and skin rejuvenation
#428FGF modulation of in vivo antibody production and humoral immunity
#429Use of antagonists of ghrelin or ghrelin receptor to prevent or treat stress-sensitive psychiatric illness
#430Cyclosporin analogues for preventing or treating hepatitis C infection
#431Stable veterinary combination formulations of macrocyclic lactones and imidazothiazoles
#432Optogenetic control of behavioral state
#433COMPOSITION FOR REGENERATING NORMAL TISSUE FROM FIBROTIC TISSUE
#434Cardiac arrest muscle relaxant
#435Methods and compositions for restoring homeostatic capacity of a subject
#436Composition for inducing proliferation or accumulation of regulatory T cells
#437Use of TRMP8 for treating opthalmic diseases or conditions involving tearing
#438Use of antagonists of ghrelin or ghrelin receptor to prevent or treat stress-sensitive psychiatric illness
#439Compositions and methods for inhibiting viral entry
#440Pharmaceutical composition
#441Method of treating depression
#442SYSTEMS AND METHODS FOR IDENTIFYING CANCERS HAVING ACTIVATED PROGESTERONE RECEPTORS
#443Therapeutic or prophylactic agent for retinopathy of prematurity, testing method for retinopathy of prematurity, and screening method for therapeutic or prophylactic substance for retinopathy of prematurity
#444Modulation of CCR10 signals for treatment of skin and intestinal inflammatory diseases and infection
#445Use of miR-221 and 222 lowering agents to prevent cardiovascular disease in diabetic subjects
#446Bicyclic substituted pyrimidine compounds
#447Compositions for the transdermal delivery of physiologically active agents
#448Dual-acting imidazole antihypertensive agents
#449Implant for tissue repair including chitosan
#450Lipoprotein complexes and manufacturing and uses thereof
#451Crystalline forms of a biphenyl compound
#4522-((R)-2-methylpyrrolidin-2-yl)-1H-benzimidazole-4-carboxamide crystalline form 1
#453AMPK activator screening method, and AMPK activator
#454Protection from chemical-induced acute lung injury
#455Tyrosine derivatives and compositions comprising them
#456VEGF binding antibodies
#457Prophylactic or therapeutic agent for hepatic diseases
#458Cationic Liposomal Drug Delivery System for Specific Targeting of Human CD14+ Monocytes in Whole Blood
#459Dual-acting antihypertensive agents
#460Component and method for treating viral disease
#461Compositions and methods for the treatment of retinal degeneration
#462HCN inhibitors affecting ganglion cell function and visual function
#463Methods to modulate Rac1 import and to treat pulmonary fibrosis
#464Pyrazolopyridinone derivatives as LPA receptor antagonists
#465Benzene, pyridine, and pyridazine derivatives
#466Methods of treating lung cancer
#467Thiolated hyaluronan-based hydrogels cross-linked using oxidized glutathione
#468Method for delivering liraglutide preparations into a lumen of the intestinal tract using a swallowable drug delivery device
#469Dual-acting imidazole antihypertensive agents
#470METHOD FOR TREATING TYPE I AND TYPE II DIABETES
#471Methods and materials for treating cancer
#472Penetrating pharmaceutical foam
#473Methods of diagnosing and treating neonatal reversion to fetal consciousness
#474Diagnosis of respiratory tract infectious disease using blood specimens
#475Lipoprotein complexes and manufacturing and uses thereof
#476Topical Transdermal Method for Delivering Nutrients Through the Skin for Expeditied Wound Healing and Skin Rejuvenation
#477Reducing short-chain fatty acids and energy uptake in obese humans by managing their intestinal microbial communities
#478Diagnosis of respiratory tract infectious diseases using urine specimens
#479Methods and formulations for treating cardiovascular disease
#480BIOMARKER-TARGETING CONTRAST AGENTS AND THEIR USE IN MAGNETIC RESONANCE IMAGING FOR DETECTION OF ATHEROSCLEROTIC PLAQUE
#481GENETIC POLYMORPHISMS ASSOCIATED WITH VENOUS THROMBOSIS AND STATIN RESPONSE, METHODS OF DETECTION AND USES THEREOF
#482Nucleoside phosphoramidates
#483MEDICINAL TREATMENT OF ATOPIC INFLAMMATORY DISEASES
#484Modified vitamin K-dependent polypeptides
#485Methods and formulations promoting tissue/organ regeneration, longevity and healthspan
#486Substituted carbamoylmethylamino acetic acid derivatives as novel NEP inhibitors
#487Compositions and methods for the treatment of cancer
#488OSTEOPOROSIS ASSOCIATED MARKERS AND METHODS OF USE
#489Methods and devices for treating parasympathetic bias mediated conditions
#490ASSAY FOR ARGINYL HYDROXYLASE ACTIVITY
#491Peptidic activators of type I cGMP dependent protein kinases and uses thereof
#492Intermediates for preparing dual-acting benzyl triazole antihypertensive agents having angiotensin II type I receptor antagonist activity and neprilysin-inhibition activity
#493MODULATORS FOR TRPA1 FOR THE TREATMENT OF ROSACEA
#494BARLEY PROTEIN MICROCAPSULES
#495Method for the treatment of neurodegenerative diseases
#496TETRAMERIC ALPHA-SYNUCLEIN AND USE THEREOF
#497Compositions Targeting the Soluble Extracellular Domain of E-Cadherin and Related Methods for Cancer Therapy
#498Purified Amphiphilic Peptide Compositions and Uses Thereof
#499Ophthalmic composition comprising ws-12 and methods to treat xerophthalmia
#500FGF modulation of in vivo antibody production and humoral immunity
#501CELLULAR BLOOD MARKERS FOR EARLY DIAGNOSIS OF ALS AND FOR ALS PROGRESSION
#502REDUCING SHORT-CHAIN FATTY ACIDS AND ENERGY UPTAKE IN OBESE HUMANS BY MANAGING THEIR INTESTINAL MICROBIAL COMMUNITIES
#503DIAGNOSIS AND TREATMENT OF BRAIN TUMORS
#504Method of treating chronic obstructive pulmonary disease
#505METHOD FOR THE PROGNOSIS OF THE PROGRESSION OF CANCER
#506Agents and method for treating inflammation-related conditions and diseases
#507METHODS AND KITS FOR PREDICTING THE RISK OF DIABETES ASSOCIATED COMPLICATIONS USING GENETIC MARKERS AND ARRAYS
#508Copy Number Variant-Dependent Genes As Diagnostic Tools, Predictive Biomarkers And Therapeutic Targets
#509Protection and treatment against influenza infection
#510Methods for Fructanase and Fructokinase Inhibition
#511Polysaccharide-based polymer tissue adhesive for medical use
#512Method of treating depression
#513METHOD FOR PREPARATION OF NICOTINIC ACID COPPER CHLORIDE COMPLEX, AND ITS PHARMACEUTICAL USES
#514COMBINATION OF SILOXANE AND ACTIVE INGREDIENT FOR TREATING DENTAL DISORDER
#515ANTITUMOR COMBINATIONS CONTAINING A VEGF-INHIBITING AGENT AND 5FU OR A DERIVATIVE THEREOF
#516PHARMACEUTICAL COMPOSITIONS FOR CALANOLIDES, THEIR DERIVATIVES AND ANALOGUES, AND PROCESS FOR PRODUCING THE SAME
#517Means of inducing cellular exocytosis and uses thereof
#518NEUROPILIN AS A BIOMARKER FOR BEVACIZUMAB COMBINATION THERAPIES
#519Methods of Treating Hepatitis With Anti-TNF alpha Antibodies
#520Cyclosporin analogues for preventing or treating hepatitis C infection
#521Antagonists of IL-6 to raise albumin and/or lower CRP
#522Penetrating pharmaceutical foam
#523Low molecular weight cationic lipids for oligonucleotide delivery
#524COMBINATION OF TESTOSTERONE AND ORNITHINE DECARBOXYLASE (ODC) INHIBITORS
#525Methods of treating an inflammatory-related disease
#526Growth inhibitory effects of nanoparticles containing triterpene glycosides or triterpenes
#527Pharmaceutical compositions comprising cyclosporin
#528EGFR aptamer inhibitor for use in therapy and diagnosis
#529NEUROPILIN AS A BIOMARKER FOR BEVACIZUMAB COMBINATION THERAPIES
#530TREATING NEOPLASMS WITH NEUROTOXIN
#531EXTRACT OF AERIAL PARTS OF MACA RICH IN POLYPHENOLS AND COMPOSITION COMPRISING SAME
#532ANTIBODIES FOR THE TREATMENT OF HIV
#533PROGNOSIS AND TREATMENT OF BREAST CANCER
#534Compositions and methods for treating hoof diseases
#535COMBINATION OF EGCG OR METHYLATED EGCG AND A PDE INHIBITOR
#536Homopiperazine derivatives as protein tyrosine kinase inhibitors and pharmaceutical use thereof
#537Modified vitamin K-dependent polypeptides
#538Therapeutic agent preparations comprising liraglutide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
#539COMPOSITIONS AND METHODS FOR THE PREVENTION OF OXIDATIVE DEGRADATION OF PROTEINS
#540METHOD AND COMPOSITION FOR THE TREATMENT OF DISEASES CAUSED BY OR ASSOCIATED WITH HIV
#541COMBINATION OF HDAC INHIBITORS WITH THROMBOCYTOPENIA DRUGS
#542COMPOSITION FOR REGENERATING NORMAL TISSUE FROM FIBROTIC TISSUE
#543Heterocyclic flaviviridae virus inhibitors
#544Extract of the above-ground portions of gynandropsis gynandra or cleome gynandra, and cosmetic, dermatological or pharmaceutical compositions including same
#5451,5-Diary1-2-alkylpyrrole-3-substituted nitro esters, selective COX-2 inhibitors and nitric oxide donors
#546Pyrazolopyridinone derivatives as LPA receptor antagonists
#547Nucleoside phosphoramidates
#548TREATMENT OF CYSTIC FIBROSIS USING CALCIUM LACTATE, LEUCINE AND SODIUM CHLORIDE IN A RESPIRAPLE DRY POWDER
#549METHODS FOR ENHANCING IMMUNE RESPONSE
#550VEGF/DLL4 binding agents and uses thereof
#551COMPOSITIONS AND METHODS FOR INHIBITING VIRAL AND BACTERIAL ACTIVITY
#552Compositions and Methods for Depleting Mutant p53
#553Methylene Urea Derivatives
#554HIGH-PURITY TEXAPHYRIN METAL COMPLEXES
#555Lytic-peptide-Her2/neu (human epidermal growth factor receptor 2) ligand conjugates and methods of use
#556COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER
#557Controlled release pharmaceutical compositions of milnacipran
#558INHIBITORS OF THE UNFOLDED PROTEIN RESPONSE AND METHODS FOR THEIR USE
#559Cyclized peptidomimetic small molecule inhibitors of the WDR5 and MLL1 interaction
#560COMPOSITION FOR INDUCING PROLIFERATION OR ACCUMULATION OF REGULATORY T CELLS
#561Serotonin reuptake inhibitors as drugs having peripheral-system-restricted activity
#562CHLORTHALIDONE COMBINATIONS
#563COMPOSITIONS AND METHODS OF TREATING A PROLIFERATIVE DISEASE WITH A QUINAZOLINONE DERIVATIVE
#564COMBINATION THERAPIES TO TREAT DIABETES
#565Method and system for adding sensory conditioning cues in a pharmacotherapeutic regimen
#566Compositions containing micronized tanaproget prepared by wet granulation
#567Compositions and methods for gene silencing
#568BENZENE, PYRIDINE, AND PYRIDAZINE DERIVATIVES
#569Functionally selective ligands of dopamine Dreceptors
#570Acellular bioabsorbable tissue regeneration matrices
#571Inhibition and dispersion of bacterial biofilms with 2-aminobenzimidazole derivatives
#572METHODS OF TREATING CANCER
#573Limited release lingual thioctic acid delivery systems
#574Method of using dopamine reuptake inhibitors and their analogs for treating diabetes symptoms and delaying or preventing diabetes-associated pathologic conditions
#575Phthalazinone ketone derivative, preparation method thereof, and pharmaceutical use thereof
#576THERAPEUTIC COMBINATION COMPRISING A PARP-1 INHIBITOR AND AN ANTI-NEOPLASTIC AGENT
#577Conjugated blood coagulation factor VIIa
#578Thienopyridine Derivatives for the Treatment and Prevention of Dengue Virus Infections
#579Tripeptides Incorporating Deuterium as Inhibitors of Hepatitis C Virus
#580Crystalline forms of a biphenyl compound
#5812-((R)-2-METHYLPYRROLIDIN-2-YL)-1H-BENZIMIDAZOLE-4-CARBOXAMIDE CRYSTALLINE FORM 1
#582MODULATORS OF PHARMACOKINETIC PROPERTIES OF THERAPEUTICS
#583Inhibition of Mitogen-activated Protein Kinases in Cardiovascular Disease
#584Arylamide derivatives having antiandrogenic properties
#585Tetrahydrocarboline derivative
#586OPTIMIZED DEGENERATIVE MUSCLE DISEASE DIAGNOSTICS AND TREATMENTS
#587Substituted carbamoylmethylamino acetic acid derivatives as novel NEP inhibitors
#588Dual-acting benzyl triazole antihypertensive agents having angiotensin II type receptor antagonist activity and neprilysin-inhibition activity
#589Substituted aminopropionic derivatives as neprilysin inhibitors
#590Compounds and methods for the treatment or prevention of infections
#591LATENT HUMAN IMMUNODEFICIENCY VIRUS REACTIVIATION
#592Methods and formulations for modulating lyn kinase activity and treating related disorders
#593Anti-CD74 immunoconjugates and methods
#594Implant for tissue repair including chitosan
#595TOPICAL TRANSDERMAL METHOD FOR DELIVERING NUTRIENTS THROUGH THE SKIN FOR EXPEDITED WOUND HEALING
#596FKBP52-tau interaction as a novel therapeutical target for treating the neurological disorders involving tau dysfunction
#597Dual-acting antihypertensive agents
#598LIPOPROTEIN COMPLEXES AND MANUFACTURING AND USES THEREOF
#599Compositions and methods for modifying a silicone surface for prolonged interference against pathogen colonization
#600METHODS FOR PROTECTING DOPAMINERGIC NEURONS FROM STRESS AND PROMOTING PROLIFERATION AND DIFFERENTIATION OF OLIGODENDROCYTE PROGENITORS BY NRG-2